Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.

ABSTRACT:

Importance

Novel hormonal therapy (NHT) agents have been shown to prolong overall survival in numerous randomized clinical trials for patients with advanced prostate cancer (PCa). There is a paucity of data regarding the pattern of use of these agents in patients from different racial and ethnic groups.

Objective

To assess racial and ethnic disparities in the use of NHT in patients with advanced PCa.

Design, setting, and participants

This cohort study comprised all men diagnosed with de novo advanced PCa (distant metastatic [M1], regional [N1M0], and high-risk localized [N0M0] per Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy [STAMPEDE] trial criteria) with Medicare Part A, B, and D coverage between January 1, 2011, and Decem

SUBMITTER: Ma TM 

PROVIDER: S-EPMC10692845 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature